Marginal Bone Loss Around Mandibular Implant-retaining Overdentures and Implant Supported Fixed Hybrid Prosthesis

July 3, 2024 updated by: Saint-Joseph University

Marginal Bone Loss Around Mandibular Implant-retaining Overdentures and Implant Supported Fixed Hybrid Prosthesis: A 5-year Follow-up

Few if any studies have compared marginal bone loss (MBL) around implant-retaining overdentures (2 implants with locators) versus implant supported fixed hybrid prosthesis (over 4 implants) in the mandible.

Study Overview

Detailed Description

Material and Methods: Patients of the saint Joseph university dental clinics, who have already in their records peri-apical radiographs of the implants post loading, will be divided in 2 groups depending on the prosthetic treatment that they have had for 5 years in mouth, and will be recalled for a check-up session during which the investigators will take new peri-apical X-rays by means of the parallel long-cone technique for the implants that are supporting/retaining the prosthesis. A total of minimum 50 implants placed in a minimum of 19 patients will be examined. The mean mesial and distal radiographic MBL and bone to implant contact (BIC) will be recorded by comparing the two X-rays for each implant.

the investigators will also investigate the possibly related factors that may have contributed to this marginal bone loss such as the medical history, smoking habits, oral hygiene, compliance, presence of keratinized tissue and possibility of proper cleaning.

Results: the investigators aim to find a statistically significant difference in the Marginal bone loss around implants assisting these two types of prosthesis and a possible correlation with some risk and modifying factors.

Study Type

Observational

Enrollment (Estimated)

19

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beirut, Lebanon, 00000
        • Saint Joseph University of Beirut

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

To determine the sample size, a power analysis was conducted for independent Student t test using G*Power and considering a power = 80%, alpha = 5%, and an effect size = 1.06. The minimum sample size required for this study is 50 implants in total: (25 per group)

Description

Inclusion Criteria:

  • Patients treated with mandibular implant-retaining overdentures (2 implants)
  • Patients treated with mandibular implant-supported fixed hybrid prosthesis (4 implants)
  • Patients having in their records a post-loading peri-apical radiograph for the implants
  • Patients who have had their prosthesis for 5 years in mouth

Exclusion Criteria:

  • Patients treated with mandibular implant-retaining overdentures with more or less than 2 implants
  • Patients treated with mandibular implant-supported fixed hybrid prosthesis with more or less than 4 implants Patients treated with any other prosthetic option on implants Patients who don't have a post-loading peri-apical radiograph in their records

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1- hybrid prosthesis
Patients having fixed hybrid prosthesis over 4 implants in the mandible for 5 years
Peri-apical radiographs on the implants supporting the prosthesis
2- over denture
Patients having removable overdenture with locators over 2 implants in the mandible for 5 years
Peri-apical radiographs on the implants supporting the prosthesis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Marginal Bone Loss in mm (MBL)
Time Frame: 5 years
MBL in mm around implants in patients having a removable prosthesis over locators and in patients having a screw retained hybrid prosthesis
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
smoking status
Time Frame: 5 years
non smoker, smoker less than 10 cig/day, smoker more than 10 cig/day
5 years
compliance and attendance to recall sessions
Time Frame: 5 years
patient attending the recall sessions or no
5 years
keratinized tissue hight
Time Frame: 5 years
measured in mm with a periodontal probe
5 years
framework design
Time Frame: 5 years
prosthetic framework fit/misfit
5 years
age
Time Frame: 5 years
in years
5 years
health status
Time Frame: 5 years
diabetes yes/no ; cardiovascular disease yes/no
5 years
sex
Time Frame: 5 years
male female
5 years
plaque score
Time Frame: 5 years
using the modified plaque index (0 absence,1 detectable by a probe, 2 visible, 3 abundant)
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elies El Hachem, DDS, Saint Joseph University of Beirut, Faculty of dental Medicine, Periodontolgy department
  • Study Director: Nadim Mokbel, PhD, Saint Joseph University of Beirut, Faculty of dental Medicine, Periodontolgy department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2023

Primary Completion (Actual)

May 30, 2024

Study Completion (Estimated)

July 20, 2024

Study Registration Dates

First Submitted

June 24, 2024

First Submitted That Met QC Criteria

July 3, 2024

First Posted (Actual)

July 5, 2024

Study Record Updates

Last Update Posted (Actual)

July 5, 2024

Last Update Submitted That Met QC Criteria

July 3, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • USJ-2023-20

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Implant Failed

Clinical Trials on Peri-apical radiographs on the implants

Subscribe